These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 31262748)

  • 1. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury.
    Villar-Lorenzo A; Rada P; Rey E; Marañón P; Arroba AI; Santamaría B; Sáiz J; Rupérez FJ; Barbas C; García-Monzón C; Valverde ÁM; González-Rodríguez Á
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31262748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
    Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
    Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.
    McMillin M; DeMorrow S; Glaser S; Venter J; Kyritsi K; Zhou T; Grant S; Giang T; Greene JF; Wu N; Jefferson B; Meng F; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G410-G418. PubMed ID: 28751425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice.
    Liu R; Li X; Huang Z; Zhao D; Ganesh BS; Lai G; Pandak WM; Hylemon PB; Bajaj JS; Sanyal AJ; Zhou H
    Hepatology; 2018 Apr; 67(4):1441-1457. PubMed ID: 28926118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The suppression of pancreatic lipase-related protein 2 ameliorates experimental hepatic fibrosis in mice.
    Ding Z; Cheng R; Liu J; Zhao Y; Ge W; Yang Y; Xu X; Wang S; Zhang J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Mar; 1867(3):159102. PubMed ID: 34995790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury.
    Shearn CT; Anderson AL; Miller CG; Noyd RC; Devereaux MW; Balasubramaniyan N; Orlicky DJ; Schmidt EE; Sokol RJ
    Hepatol Commun; 2023 Jan; 7(1):e0020. PubMed ID: 36633484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sortilin in Biliary Epithelial Cells Promotes Ductular Reaction and Fibrosis during Cholestatic Injury.
    Hubel E; Neumann A; Fishman S; Schaffer O; Erez N; Shrkihe BA; Shteingard Y; Gross T; Shibolet O; Varol C; Zvibel I
    Am J Pathol; 2024 Jun; 194(6):941-957. PubMed ID: 38493927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice.
    Hartmann P; Haimerl M; Mazagova M; Brenner DA; Schnabl B
    Gastroenterology; 2012 Nov; 143(5):1330-1340.e1. PubMed ID: 22841787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice.
    Brea R; Casanova N; Alvarez-Lucena C; Fuertes-Agudo M; Luque-Tevar M; Cucarella C; Capitani MC; Marinochi MV; Fusini ME; Lahoz A; Nogueroles ML; Fraile J; Ronco MT; Boscá L; González-Rodríguez Á; García-Monzón C; Martín-Sanz P; Casado M; Francés DE
    Liver Int; 2024 Jun; ():. PubMed ID: 38847511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased oxidative stress and apoptosis in the hypothalamus of diabetic male mice in the insulin receptor substrate-2 knockout model.
    Baquedano E; Burgos-Ramos E; Canelles S; González-Rodríguez A; Chowen JA; Argente J; Barrios V; Valverde AM; Frago LM
    Dis Model Mech; 2016 May; 9(5):573-83. PubMed ID: 27013528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1R contributes to stress-induced hepatocellular damage in experimental cholestasis.
    Cadoret A; Rey C; Wendum D; Elriz K; Tronche F; Holzenberger M; Housset C
    Am J Pathol; 2009 Aug; 175(2):627-35. PubMed ID: 19628767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate.
    Yang J; Chen L; Zhao SS; Du C; Fan YZ; Liu HX; Li Y; Li YZ
    Front Pharmacol; 2024; 15():1422770. PubMed ID: 39040469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gut/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis.
    Xie XM; Feng S; Liu T; Feng J; Xu Y; Fan ZJ; Wang GY
    Int Immunopharmacol; 2024 Jul; 139():112747. PubMed ID: 39067396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review.
    Gui R; Li W; Li Z; Wang H; Wu Y; Jiao W; Zhao G; Shen Y; Wang L; Zhang J; Chen S; Hao L; Cheng Y
    Int J Biol Macromol; 2023 Nov; 251():126263. PubMed ID: 37567540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimized visualization and quantitative protocol for in-depth evaluation of lymphatic vessel architecture in the liver.
    Jeong J; Tanaka M; Yang Y; Arefyev N; DiRito J; Tietjen G; Zhang X; McConnell MJ; Utsumi T; Iwakiri Y
    Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G379-G390. PubMed ID: 37605828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses.
    Duan S; Li X; Han J; Yang Y; Luo R; Cai Y; Li X; Zheng Q; Guo J; Liu R
    Antioxidants (Basel); 2024 Feb; 13(3):. PubMed ID: 38539789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular crosstalk during cholestatic liver injury.
    Thomson J; Hargrove L; Kennedy L; Demieville J; Francis H
    Liver Res; 2017 Jun; 1(1):26-33. PubMed ID: 29552372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases.
    García-Ruiz I; Blanes Ruiz N; Rada P; Pardo V; Ruiz L; Blas-García A; Valdecantos MP; Grau Sanz M; Solís Herruzo JA; Valverde ÁM
    Redox Biol; 2019 Sep; 26():101263. PubMed ID: 31299613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
    Marañón P; Isaza SC; Fernández-García CE; Rey E; Gallego-Durán R; Montero-Vallejo R; de Cía JR; Ampuero J; Valverde ÁM; Romero-Gómez M; García-Monzón C; González-Rodríguez Á
    Biomark Res; 2023 Apr; 11(1):46. PubMed ID: 37106416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway
    Zhao H; Lu J; He F; Wang M; Yan Y; Chen B; Xie D; Xu C; Wang Q; Liu W; Yu W; Xi Y; Yu L; Yamamoto T; Koyama H; Wang W; Zhang C; Cheng J
    Front Immunol; 2022; 13():931087. PubMed ID: 36177037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.